Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides

A phase I clinical trial was conducted in patients with stage III/IV breast cancer who were treated with the anti-idiotype mAb 1E10 specific to an Ab1 mAb able to react specifically with N-glycolyl-containing gangliosides and with antigens expressed on human melanoma and breast carcinoma cells. Pati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical immunology (Orlando, Fla.). - 1999. - 107(2003), 2 vom: 30. Mai, Seite 80-9
1. Verfasser:	Díaz, Alain (VerfasserIn)
Weitere Verfasser:	Alfonso, Mauro, Alonso, Ruby, Saurez, Giselle, Troche, Mayelín, Catalá, Mauricio, Díaz, Rosa María, Pérez, Rolando, Vázquez, Ana María
Format:	Aufsatz
Sprache:	English
Veröffentlicht:	2003
Zugriff auf das übergeordnete Werk:	Clinical immunology (Orlando, Fla.)
Schlagworte:	Clinical Trial Clinical Trial, Phase I Journal Article Research Support, Non-U.S. Gov't Antibodies, Anti-Idiotypic Antibodies, Monoclonal Antibodies, Neoplasm Cancer Vaccines G(M3) Ganglioside